Publicaciones (28) Publicaciones de Emilio Siendones Castillo

2024

  1. Brain organoid as a model to study the role of mitochondria in neurodevelopmental disorders: achievements and weaknesses

    Frontiers in Cellular Neuroscience, Vol. 18

2019

  1. ADCK2 haploinsufficiency reduces mitochondrial lipid oxidation and causes myopathy associated with CoQ deficiency

    Journal of Clinical Medicine, Vol. 8, Núm. 9

  2. Evaluación continua formativa y formadora mediante una metodología de enseñanza híbrida inductivo-deductiva para estudiantes de farmacología aplicada al grado de nutrición humana y dietética

    Innovación Docente e Investigación en Ciencias de la Salud (Dykinson), pp. 75-86

2018

  1. Cellular and molecular mechanisms of recessive hereditary methaemoglobinaemia type II

    Journal of Clinical Medicine, Vol. 7, Núm. 10

  2. Desarrollo de habiidades metacognitivas mediante evaluaciones formadoras y dirigidas al aprendizaje.

    IV Congreso Virtual Internacional sobre Innovación Pedagógica y Praxis Educativa INNOVAGOGÍA 2018: libro de actas. 20, 21 y 22 de marzo 2018

  3. Desarrollo de habilidades metacognitivas mediante evaluaciones formadoras y dirigidas al aprendizaje

    Experiencias pedagógicas e innovación educativa: aportaciones desde la praxis docente e investigadora (Octaedro), pp. 1895-1903

2016

  1. Cytochrome b5 reductase and the control of lipid metabolism and healthspan

    npj Aging and Mechanisms of Disease, Vol. 2, Núm. 1

  2. RNA-binding proteins regulate cell respiration and coenzyme Q biosynthesis by post-transcriptional regulation of COQ7

    RNA Biology, Vol. 13, Núm. 7, pp. 622-634

2014

  1. Membrane-bound CYB5R3 is a common effector of nutritional and oxidative stress response through FOXO3a and Nrf2

    Antioxidants and Redox Signaling, Vol. 21, Núm. 12, pp. 1708-1725

2010

  1. CYB5R3: A key player in aerobic metabolism and aging?

    Aging, Vol. 2, Núm. 1, pp. 63-68

2009

  1. Cell survival from chemotherapy depends on NF-κB transcriptional up-regulation of coenzyme Q biosynthesis

    PLoS ONE, Vol. 4, Núm. 4

2008

  1. MEK inhibition induces caspases activation, differentiation blockade and PML/RARα degradation in acute promyelocytic leukaemia

    British Journal of Haematology, Vol. 142, Núm. 1, pp. 27-35

2007

  1. Inhibition of Flt3-activating mutations does not prevent constitutive activation of ERK/Akt/STAT pathways in some AML cells: A possible cause for the limited effectiveness of monotherapy with small-molecule inhibitors

    Hematological Oncology, Vol. 25, Núm. 1, pp. 30-37

  2. The calcimimetic R-568 increases vitamin D receptor expression in rat parathyroid glands

    American Journal of Physiology - Renal Physiology, Vol. 292, Núm. 5

2006

  1. Antiphospholipid antibodies from patients with the antiphospholipid syndrome induce monocyte tissue factor expression through the simultaneous activation of NF-κB/Rel proteins via the p38 mitogen-activated protein kinase pathway, and of the MEK-1/ERK pathway

    Arthritis and Rheumatism, Vol. 54, Núm. 1, pp. 301-311

  2. Antiphospholipid-mediated thrombosis: Interplay between anticardiolipin antibodies and vascular cells

    Clinical and Applied Thrombosis/Hemostasis, Vol. 12, Núm. 1, pp. 41-45

  3. Cyclin D3 expression in primary Ta/TI bladder cancer

    Journal of Pathology, Vol. 209, Núm. 1, pp. 106-113

  4. Proteomic analysis of acute myeloid leukemia: Identification of potential early biomarkers and therapeutic targets.

    Proteomics, Vol. 6 Suppl 1

  5. Tissue factor as an effector of angiogenesis and tumor progression in hematological malignancies

    Leukemia, Vol. 20, Núm. 8, pp. 1331-1340

2005

  1. PGE1 abolishes the mitochondrial-independent cell death pathway induced by D-galactosamine in primary culture of rat hepatocytes

    Journal of Gastroenterology and Hepatology (Australia), Vol. 20, Núm. 1, pp. 108-116